Donald Pinkel
Donald Paul Pinkel was an American physician who specialized in pediatric hematology and oncology. Pinkel made contributions to cures for several forms of childhood cancer, including leukemia.
He was the first director of St. Jude Children's Research Hospital in Memphis, Tennessee, serving from 1962 to 1973. He also authored or co-authored numerous books, chapters in books, and journal articles.
He received many awards and recognitions for his research work, including the Albert Lasker Award for Clinical Medical Research in 1972, the Kettering Prize for cancer research in 1986, and the Pollin Prize for Pediatric Research in 2003.
Early life and career
Pinkel was born in Buffalo, New York, on September 7, 1926. His father, Lawrence, worked as a hardware salesman; his mother, Anne, was a housewife. Pinkel graduated from Canisius High School in 1944, and enlisted in the US Navy later that year. As part of the V-12 Navy College Training Program, he studied at Cornell University, where he became interested in biology and medicine. He later went back home and graduated from Canisius College in 1947. He then entered medical school at the University at Buffalo, obtaining a medical degree in 1951. Three years later, as a pediatrician in the Army Medical Corps in Massachusetts, Pinkel contracted polio. As his condition improved, he began working with researcher Sidney Farber in Boston, experimenting with the impact of aminopterin on leukemia.Pinkel was named chief of pediatrics at Roswell Park Comprehensive Cancer Center in Buffalo in 1956. He soon began planning to relocate because of the impact of Buffalo's climate on his polio.
Director of St. Jude Children's Research Hospital
Pinkel met the Lebanese-American entertainer Danny Thomas in 1961. The latter was spearheading the foundation and construction of a children's research hospital, called after St Jude, the patron of the hopeless, to be based in Memphis, Tennessee. Pinkel visited the budding project in 1961, and decided to become a founding member, taking a significant pay reduction to make the move. He served as the first director and CEO of St. Jude Children's Research Hospital from February 1962 to 1974, focusing on Acute lymphoblastic leukemia, the most frequent cancer in young children. His team pinpointed four key obstacles to its cure: drug resistance, drug toxicity, meningeal relapse, and pessimism among doctors.Pinkel's team instituted a treatment program aimed at permanent cure of ALL. Called "Total Therapy," it was based on all the available relevant laboratory and clinical research and experience. There were four phases: remission induction, remission consolidation or intensification, specific pre-emptive meningeal treatment and continuation chemotherapy for 3 years. Both radiotherapy and instillation of drug directly into spinal fluid were used for meningeal treatment. Eventually a 50% cure rate was achieved in the 1967–68 study V; this cure rate continues for the children in this study 40 years later. This was the first significant cure rate for generalized cancer and for primarily drug treatment of cancer.
This four-phase treatment plan is still used today with numerous modifications. Increases in resources and trained physicians and nurses, better infection control, safer blood transfusion and newer drugs and drug schedules have increased the reported cure rates to 75–85% of treated children with ALL in developed countries. Better use of drugs both systemically and by instillation into the spinal fluid have replaced the need for radiation therapy to pre-empt meningeal relapse in most children with ALL.